MNTL TEMA NEUROSCIENCE AND MENTAL HEALTH ETF
- 24.520
- -0.128-0.52%
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Catalyst Watch: Netflix Earnings, Monster Beverage Event, Drug Data, and Quantum Volatility
Argenx Cut to Sell at Deutsche Bank on Valuation
How Is The Market Feeling About Eli Lilly?
Hims & Hers Health Down 3% After BoA Says Q4 Revenue Could Be a Miss
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
BofA Spotlights Four Bulls and Two Bears: LLY, TGT, PYPL, MCK, AR, and EWBC
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Even Lack of Trump Action Matters Now | Markets in 3 Minutes
FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Novo Nordisk Says Higher Wegovy Dose Caused Over 20% Weight Loss in Late-stage Trial
Teva Pharmaceutical Indus Analyst Ratings
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
Regeneron Pharmaceuticals Analyst Ratings
Eli Lilly's Options: A Look at What the Big Money Is Thinking
Here's How Much $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth Today
Least Shorted S&P 500 Stocks in December
AbbVie Retains Humira Market Share Above 70%: Report